Kiora Pharmaceuticals, Inc. - Common Stock (NQ:KPRX)
Price and Volume
Detailed Quote| Volume | 3,762 |
| Open | 2.590 |
| Bid (Size) | 2.540 (300) |
| Ask (Size) | 2.580 (100) |
| Prev. Close | 2.550 |
| Today's Range | 2.560 - 2.590 |
| 52wk Range | 1.764 - 3.290 |
| Shares Outstanding | 1,141,863 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 7, 2025 ↗
November 07, 2025
Kiora (KPRX) Q2 Revenue Falls 100% ↗
August 08, 2025
Which stocks have an unusual volume on Wednesday? ↗
June 04, 2025
Wednesday's session: gap up and gap down stocks ↗
June 04, 2025
These stocks are moving in today's pre-market session ↗
June 04, 2025
A Look Into Healthcare Sector Value Stocks ↗
March 11, 2024
Frequently Asked Questions
Is Kiora Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Kiora Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Kiora Pharmaceuticals, Inc. - Common Stock trade on?
Kiora Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kiora Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Kiora Pharmaceuticals, Inc. - Common Stock is KPRX on the Nasdaq Stock Market
What is the current price of Kiora Pharmaceuticals, Inc. - Common Stock?
The current price of Kiora Pharmaceuticals, Inc. - Common Stock is 2.560
When was Kiora Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Kiora Pharmaceuticals, Inc. - Common Stock was at 07/07/26 02:51 PM ET
What is the market capitalization of Kiora Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Kiora Pharmaceuticals, Inc. - Common Stock is 2.92M
How many shares of Kiora Pharmaceuticals, Inc. - Common Stock are outstanding?
Kiora Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.